Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: findings from a randomised trial.

[1]  R. Sun,et al.  A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma. , 2012, Oral oncology.

[2]  Jin-Ching Lin,et al.  Current management of nasopharyngeal cancer. , 2012, Seminars in radiation oncology.

[3]  Lori Minasian,et al.  The Role of Obesity in Cancer Survival and Recurrence , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[4]  T. Yen,et al.  Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation. , 2012, International Journal of Radiation Oncology, Biology, Physics.

[5]  A. Fortin,et al.  Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer , 2012, Supportive Care in Cancer.

[6]  C. Punt,et al.  Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. , 2011, European journal of cancer.

[7]  T. Bjørge,et al.  High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer , 2011, British Journal of Cancer.

[8]  M. Ewertz,et al.  Effect of obesity on prognosis after early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Saraswathi,et al.  Cancer cachexia , 2011, Journal of oral and maxillofacial pathology : JOMFP.

[10]  M. Palma,et al.  Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment , 2010, Supportive Care in Cancer.

[11]  Yun-Fei Xia,et al.  [Impact of pretherapy body mass index on prognosis of nasopharyngeal carcinoma]. , 2009, Ai zheng = Aizheng = Chinese journal of cancer.

[12]  K. Münstedt,et al.  Influence of body mass index on prognosis in gynecological malignancies , 2008, Cancer Causes & Control.

[13]  G. Hortobagyi,et al.  Prognostic Value of Body Mass Index in Locally Advanced Breast Cancer , 2008, Clinical Cancer Research.

[14]  J. Shao,et al.  Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma , 2008, Journal of Translational Medicine.

[15]  A. Renshaw,et al.  Influence of body mass index on prostate‐specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer , 2007, Cancer.

[16]  J. Stanford,et al.  Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men , 2007, Cancer.

[17]  Young Ho Yun,et al.  Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Cheville,et al.  Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. , 2006, Urology.

[19]  J. Pignon,et al.  Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. , 2006, International journal of radiation oncology, biology, physics.

[20]  B. O'Sullivan,et al.  Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Andy H. Lee,et al.  Body Mass Index in Relation to Ovarian Cancer Survival , 2005, Cancer Epidemiology Biomarkers & Prevention.

[22]  E. Van Cutsem,et al.  The causes and consequences of cancer-associated malnutrition. , 2005, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[23]  J. Sham,et al.  Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone. , 2004, Cancer.

[24]  J. Sham,et al.  Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone , 2004 .

[25]  J. Sham,et al.  Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[26]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[27]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[28]  C. Gwede,et al.  Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Jun Ma,et al.  A comparison of the Chinese 1992 and fifth‐edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma , 2000, Cancer.

[30]  L. Tai.  A probe of design methods of block shielding facio cervical portals at isocentre for radiotherapy of nasopharyngeal carcinoma , 2000 .

[31]  L. Laliberte,et al.  The Karnofsky performance status scale: An examination of its reliability and validity in a research setting , 1984, Cancer.

[32]  D. A. BRUNNING,et al.  European Journal of Cancer , 1966, Nature.